Literature DB >> 9360516

Cigarette smoking and insulin resistance in patients with noninsulin-dependent diabetes mellitus.

G Targher1, M Alberiche, M B Zenere, R C Bonadonna, M Muggeo, E Bonora.   

Abstract

To evaluate the effects of chronic cigarette smoking on insulin sensitivity in patients with noninsulin-dependent diabetes mellitus (NIDDM), we examined 28 smokers and 12 nonsmokers with NIDDM, of similar sex, age, body mass index, waist/hip ratio, alcohol consumption, physical activity level, glycometabolic control, diabetes duration, and treatment. Insulin and C-peptide responses to oral glucose load were significantly higher in smokers than nonsmokers, whereas glucose levels were not substantially different. During insulin clamp (20 mU/min.m2), carried out in combination with tritiated glucose infusion and indirect calorimetry, total glucose disposal was markedly reduced in smokers vs. nonsmokers [19 +/- 1.2 vs. 33 +/- 5 mumol/min.kg fat-free mass (FFM); P < 0.001], in a dose-dependent fashion (F = 6.8, P < 0.001 by ANOVA when subjects were categorized for number of cigarettes smoked per day). Oxidative (9 +/- 1 vs. 14 +/- 2 mumol/min.kg FFM; P < 0.01) and nonoxidative (10 +/- 1 vs. 19 +/- 4 mumol/min.kg FFM; P < 0.01) pathways of insulin-mediated intracellular glucose metabolism were similarly reduced in smokers vs. nonsmokers. Plasma free fatty acid levels (240 +/- 33 vs. 130 +/- 23 microEq/L; P < 0.05) and lipid oxidation rate (1.39 +/- 0.1 vs. 0.95 +/- 0.2 mumol/ min.kg FFM; P < 0.05) were less suppressed by hyperinsulinemia in smokers than nonsmokers. In conclusion, chronic cigarette smoking seems to markedly aggravate insulin resistance in patients with NIDDM.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9360516     DOI: 10.1210/jcem.82.11.4351

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  44 in total

Review 1.  Treatment of coexisting diabetes and hypertension.

Authors:  N M Kaplan
Journal:  Curr Cardiol Rep       Date:  2001-11       Impact factor: 2.931

Review 2.  The metabolic syndrome and related cardiovascular risk.

Authors:  F Ramos; H P Baglivo; A J Ramírez; R Sánchez
Journal:  Curr Hypertens Rep       Date:  2001-04       Impact factor: 5.369

3.  Insulin Resistance in Young Obese Subjects and Its Relation to Smoking (A Pilot Study).

Authors:  Aarzoo Juneja; Shridhar Dwivedi; D K Srivastava; Kailash Chandra
Journal:  Indian J Clin Biochem       Date:  2016-05-24

Review 4.  Metabolic effects of smoking cessation.

Authors:  Kindred K Harris; Mohan Zopey; Theodore C Friedman
Journal:  Nat Rev Endocrinol       Date:  2016-03-04       Impact factor: 43.330

Review 5.  The Effect of Cigarette Smoking on Diabetic Peripheral Neuropathy: A Systematic Review and Meta-Analysis.

Authors:  Carole Clair; Marya J Cohen; Florian Eichler; Kevin J Selby; Nancy A Rigotti
Journal:  J Gen Intern Med       Date:  2015-05-07       Impact factor: 5.128

Review 6.  Smoking and the risk of type 2 diabetes.

Authors:  Judith Maddatu; Emily Anderson-Baucum; Carmella Evans-Molina
Journal:  Transl Res       Date:  2017-03-06       Impact factor: 7.012

7.  Smoking is Associated With Increased Risk of Not Achieving Glycemic Target, Increased Glycemic Variability, and Increased Risk of Hypoglycemia for People With Type 1 Diabetes.

Authors:  Morten Hasselstrøm Jensen; Simon Lebech Cichosz; Irl B Hirsch; Peter Vestergaard; Ole Hejlesen; Edmund Seto
Journal:  J Diabetes Sci Technol       Date:  2020-05-26

8.  Socio-demographic Determinants of Compliance among Type 2 Diabetic Patients in Abha, Saudi Arabia.

Authors:  Mohammad Abdul Salam; Aesha Farheen Siddiqui
Journal:  J Clin Diagn Res       Date:  2013-11-21

9.  Synergistic effect of fatty liver and smoking on metabolic syndrome.

Authors:  Po-Hsin Chiang; Tsui-Yen Chang; Jong-Dar Chen
Journal:  World J Gastroenterol       Date:  2009-11-14       Impact factor: 5.742

Review 10.  Inhaled insulin: overview of a novel route of insulin administration.

Authors:  Lucy D Mastrandrea
Journal:  Vasc Health Risk Manag       Date:  2010-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.